Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors. 2014

Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
Clinical Research Division, Fred Hutchinson Cancer Research Center , 1100 Fairview Avenue North, Seattle, Washington 98109, United States.

Sirtuins are a family of NAD(+)-dependent protein deacetylases that play critical roles in epigenetic regulation, stress responses, and cellular aging in eukaryotic cells. In an effort to identify small molecule inhibitors of sirtuins for potential use as chemotherapeutics as well as tools to modulate sirtuin activity, we previously identified a nonselective sirtuin inhibitor called cambinol (IC50 ≈ 50 μM for SIRT1 and SIRT2) with in vitro and in vivo antilymphoma activity. In the current study, we used saturation transfer difference (STD) NMR experiments with recombinant SIRT1 and 20 to map parts of the inhibitor that interacted with the protein. Our ongoing efforts to optimize cambinol analogues for potency and selectivity have resulted in the identification of isoform selective analogues: 17 with >7.8-fold selectivity for SIRT1, 24 with >15.4-fold selectivity for SIRT2, and 8 with 6.8- and 5.3-fold selectivity for SIRT3 versus SIRT1 and SIRT2, respectively. In vitro cytotoxicity studies with these compounds as well as EX527, a potent and selective SIRT1 inhibitor, suggest that antilymphoma activity of this compound class may be predominantly due to SIRT2 inhibition.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D047069 Pyrazolones Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production. Pyrazolin-5-Ones,Pyrazolin 5 Ones
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D037761 Sirtuins A homologous family of regulatory enzymes that are structurally related to the protein silent mating type information regulator 2 (Sir2) found in Saccharomyces cerevisiae. Sirtuins contain a central catalytic core region which binds NAD. Several of the sirtuins utilize NAD to deacetylate proteins such as HISTONES and are categorized as GROUP III HISTONE DEACETYLASES. Several other sirtuin members utilize NAD to transfer ADP-RIBOSE to proteins and are categorized as MONO ADP-RIBOSE TRANSFERASES, while a third group of sirtuins appears to have both deacetylase and ADP ribose transferase activities. SIRT,Sir2-like Proteins,Sirtuin,SIRTs,Silent Mating Type Information Regulator 2-like Proteins,Silent Mating Type Information Regulator 2 like Proteins,Sir2 like Proteins

Related Publications

Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
May 2009, Journal of medicinal chemistry,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
August 2011, Chemistry, an Asian journal,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
November 2012, ChemMedChem,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
November 2014, European journal of medicinal chemistry,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
April 2016, Journal of medicinal chemistry,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
March 2018, Journal of medicinal chemistry,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
April 2020, Archiv der Pharmazie,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
November 2012, Acta crystallographica. Section E, Structure reports online,
Sumit S Mahajan, and Michele Scian, and Smitha Sripathy, and Jeff Posakony, and Uyen Lao, and Taylor K Loe, and Vid Leko, and Angel Thalhofer, and Aaron D Schuler, and Antonio Bedalov, and Julian A Simon
May 2014, Future medicinal chemistry,
Copied contents to your clipboard!